Abstract
Aspartate transcarbamoylase (ATC) is a key enzyme involved in pyrimidine biosynthesis and is required for the proliferation of parasites and cancer cells. Chemicals blocking ATC function would be valuable for anti-malaria drug development and cancer therapy. In this thesis, we detail the discovery of a class of small-molecule allosteric inhibitors of ATCs, termed the BDA series, mainly focusing on reporting a previously unreported allosteric pocket, which reveals an allosteric mechanism of inhibition. This allosteric pocket greatly enhances the drug ability of ATC and represents an attractive target for the development of new ATC inhibitors for anti-malaria or cancer therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
